This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Monday's Late Winners & Losers

Stocks were relatively quiet after the bell Monday despite a flowering earnings season, but among the winners was Robbins & Myers (RBN).

The Dayton, Ohio, company, which makes equipment for the pharmaceutical, energy and industrial markets, said fiscal fourth-quarter earnings jumped 64.1% year-over-year to $1.05 a share, excluding items. Analysts polled by Thomson Financial were looking for just 84 cents a share. Robbins stock added $3.66, or 6%, to $64.75.

Trucking company Werner Enterprises (WERN), based in Omaha, Neb., pocketed third-quarter income of $21.9 million, or 30 cents a share, a penny over the average Street estimate. Shares, however, were recently trading lower 0.5% to $17.50 in choppy post-bell trading.

Zila (ZILA), which makes oral-disease treatments, was in the green after narrowing its fourth-quarter continuing-operations loss to $5.8 million, or 9 cents a share, vs. 17 cents a share last year. The sole analyst's estimate called for a loss of a nickel a share, excluding items. Shares of the Phoenix-based company added 13.9% to $1.15 in light trading.

On the other hand, OSI Pharmaceuticals (OSIP) slipped after reporting an "unusually high" rate of expiring product returns for its Tarceva cancer treatment, which necessitated about a $13 million reserve adjustment in the third quarter. OSI nonetheless reaffirmed its prior full-year Tarceva sales guidance of between $855 million and $860 million. Still, OSI shares fell 1.6% to $35.10.

Genentech (DNA), Tarceva's U.S. distributor, was off 1% to $76.76, even though the South San Francisco, Calif., biotech posted a non-GAAP profit of 73 cents a share in that quarter. That's a penny over earnings targets. Revenue, at $2.91 billion, was a hair under.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs